SAR-154782

N/A

Report date: 2025/01/26 17:57:49
NME

Base Information

Drug NameSAR-154782
Drug Alias NameNAMPT inhibitor (Sanofi)SAR-154782
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors
TargetsNicotinamide phosphoribosyltransferase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A